PepGen (PEPG) Competitors $1.22 +0.01 (+0.83%) Closing price 07/3/2025 02:21 PM EasternExtended Trading$1.24 +0.02 (+1.64%) As of 07/3/2025 04:43 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock PEPG vs. ACIU, CTOR, CTMX, EDIT, TLSA, TIL, OGI, CYBN, NVCT, and SPROShould you be buying PepGen stock or one of its competitors? The main competitors of PepGen include AC Immune (ACIU), Citius Oncology (CTOR), CytomX Therapeutics (CTMX), Editas Medicine (EDIT), Tiziana Life Sciences (TLSA), Instil Bio (TIL), Organigram Global (OGI), Cybin (CYBN), Nuvectis Pharma (NVCT), and Spero Therapeutics (SPRO). These companies are all part of the "pharmaceutical products" industry. PepGen vs. Its Competitors AC Immune Citius Oncology CytomX Therapeutics Editas Medicine Tiziana Life Sciences Instil Bio Organigram Global Cybin Nuvectis Pharma Spero Therapeutics AC Immune (NASDAQ:ACIU) and PepGen (NASDAQ:PEPG) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, valuation, dividends, profitability, risk, analyst recommendations, institutional ownership and media sentiment. Does the media refer more to ACIU or PEPG? In the previous week, PepGen had 20 more articles in the media than AC Immune. MarketBeat recorded 21 mentions for PepGen and 1 mentions for AC Immune. AC Immune's average media sentiment score of 0.59 beat PepGen's score of 0.16 indicating that AC Immune is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AC Immune 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive PepGen 0 Very Positive mention(s) 3 Positive mention(s) 18 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has higher earnings and valuation, ACIU or PEPG? AC Immune has higher revenue and earnings than PepGen. AC Immune is trading at a lower price-to-earnings ratio than PepGen, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAC Immune$28.30M7.31-$57.83M-$0.58-3.55PepGenN/AN/A-$89.98M-$3.13-0.39 Do institutionals & insiders have more ownership in ACIU or PEPG? 51.4% of AC Immune shares are owned by institutional investors. Comparatively, 58.0% of PepGen shares are owned by institutional investors. 4.6% of AC Immune shares are owned by company insiders. Comparatively, 5.2% of PepGen shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Is ACIU or PEPG more profitable? PepGen has a net margin of 0.00% compared to AC Immune's net margin of -177.79%. AC Immune's return on equity of -44.60% beat PepGen's return on equity.Company Net Margins Return on Equity Return on Assets AC Immune-177.79% -44.60% -22.25% PepGen N/A -81.26%-63.65% Which has more volatility & risk, ACIU or PEPG? AC Immune has a beta of 1.62, meaning that its stock price is 62% more volatile than the S&P 500. Comparatively, PepGen has a beta of 1.16, meaning that its stock price is 16% more volatile than the S&P 500. Do analysts rate ACIU or PEPG? AC Immune currently has a consensus price target of $12.00, indicating a potential upside of 482.52%. PepGen has a consensus price target of $7.67, indicating a potential upside of 528.42%. Given PepGen's higher probable upside, analysts clearly believe PepGen is more favorable than AC Immune.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score AC Immune 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00PepGen 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33 SummaryAC Immune beats PepGen on 8 of the 15 factors compared between the two stocks. Get PepGen News Delivered to You Automatically Sign up to receive the latest news and ratings for PEPG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PEPG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PEPG vs. The Competition Export to ExcelMetricPepGenMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$39.92M$2.91B$5.56B$9.04BDividend YieldN/A2.44%5.22%3.99%P/E Ratio-0.3921.5627.6620.25Price / SalesN/A280.84421.61119.11Price / CashN/A42.7336.8958.10Price / Book0.347.518.035.67Net Income-$89.98M-$55.14M$3.18B$249.21M7 Day Performance6.09%4.61%2.93%3.28%1 Month Performance-18.67%0.90%1.72%3.95%1 Year Performance-92.76%5.40%34.39%20.98% PepGen Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PEPGPepGen2.9401 of 5 stars$1.22+0.8%$7.67+528.4%-92.8%$39.92MN/A-0.3930ACIUAC Immune2.4459 of 5 stars$1.83-2.7%$12.00+555.7%-42.6%$188.77M$31.02M-3.16140CTORCitius Oncology0.3909 of 5 stars$2.50-4.9%$3.00+20.0%N/A$188.18MN/A0.00N/ANews CoverageGap DownCTMXCytomX Therapeutics4.0629 of 5 stars$2.16-6.9%$5.33+146.9%+93.0%$187.04M$138.10M4.50170EDITEditas Medicine4.1991 of 5 stars$2.10-5.4%$4.70+123.8%-43.7%$185.84M$32.31M-0.69230TLSATiziana Life Sciences0.6752 of 5 stars$1.55-0.6%N/A+85.5%$182.28MN/A0.008TILInstil Bio2.6125 of 5 stars$29.84+7.7%$119.00+298.8%+185.4%$181.68MN/A-2.49410News CoverageOGIOrganigram Global0.5281 of 5 stars$1.28-0.8%N/A-10.4%$172.78M$117.47M12.80860News CoverageCYBNCybin2.9615 of 5 stars$7.41-4.8%$86.00+1,060.6%N/A$170.39MN/A-1.6950News CoverageAnalyst RevisionGap UpNVCTNuvectis Pharma2.6415 of 5 stars$7.96-2.1%$17.00+113.6%+24.6%$169.86MN/A-7.048SPROSpero Therapeutics3.8996 of 5 stars$2.93-3.0%$5.00+70.6%+122.1%$168.85M$47.98M-2.29150 Related Companies and Tools Related Companies AC Immune Alternatives Citius Oncology Alternatives CytomX Therapeutics Alternatives Editas Medicine Alternatives Tiziana Life Sciences Alternatives Instil Bio Alternatives Organigram Global Alternatives Cybin Alternatives Nuvectis Pharma Alternatives Spero Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PEPG) was last updated on 7/6/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored140% Yields From Stocks Like Tesla? Here's How (July 4th Special)Imagine getting a 140% dividend from your investments. Even better? It works with big names like Tesla, ...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe day and month stocks are most likely to crash nextGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PepGen, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PepGen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
